Transaction #21507 · Form 4 · 0001193125-25-323332
Kyverna Therapeutics, Inc. · Exercise / conversion · Common Stock
Kyverna Therapeutics, Inc. · Transacted December 15, 2025 · Filed December 17, 2025
What does this filing report?
An SEC Form 4 filing for Kyverna Therapeutics, Inc. records an exercise / conversion involving Common Stock on December 15, 2025. The reported quantity was 23,998. The filing date is December 17, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Kyverna Therapeutics, Inc.
- Company CIK
- 0001994702
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 23,998
- Reported price
- 4.83
- Reference value
- 115,910.34
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 46,634
- Ownership description
- Not reported
- SEC acceptance time
- Dec 17, 2025, 8:30 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Walker Karen Marie ↗
Chief Technology Officer
CIK 0002008556
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.
- F2
- 25% of the original number of shares subject to the option vested on January 1, 2025, and 1/48th of the original number of shares subject to the option vests in monthly installments thereafter, subject to the Reporting Person's continuous service.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.